Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Europe has a new mosquito problem, but it may not be the one you think

2

Sep 2026

Europe has a new mosquito problem, but it may not be the one you think

A scoping review of 91 studies, combined with a workshop involving 41 experts from six European countries, mapped the spread, biology, surveillance challenges, and potential disease relevance of the invasive mosquito Aedes koreicus. The researchers identified major gaps in species identification, vector competence, ecology, genetics, and long-term surveillance that must be addressed as the cold-tolerant mosquito expands across Europe.

Coffee’s link to Parkinson’s risk may depend on how your body handles caffeine

2

Sep 2026

Coffee’s link to Parkinson’s risk may depend on how your body handles caffeine

In 435,551 UK Biobank participants followed for a median of 15.7 years, overall coffee consumption was not associated with Parkinson’s disease risk, but the relationship differed significantly according to CYP1A2 genotype. Lower risk was observed with low-to-moderate coffee intake among fast-metabolizer AA carriers, while higher intake was associated with increased risk among AC and CC carriers, although the observational findings do not establish causality and sex-specific patterns require cautious interpretation.

Alcohol-related liver cancer deaths were falling. Then the trend reversed during the COVID-19 pandemic

1

Sep 2026

Alcohol-related liver cancer deaths were falling. Then the trend reversed during the COVID-19 pandemic

A global analysis of GBD 2023 data found that alcohol-attributable liver cancer mortality increased modestly from 1990 to 2023, while mortality from alcohol-attributable cirrhosis, alcoholic cardiomyopathy, and alcohol use disorders declined. Liver cancer mortality shifted from a pre-pandemic decline to an increase during 2020–2023, particularly among women, although the researchers cautioned that the ecological analysis cannot establish that pandemic-related changes caused the reversal.

The global toll of snakebite may be much bigger than we thought

1

Sep 2026

The global toll of snakebite may be much bigger than we thought

A global literature review and geostatistical modeling study estimated the burden of snake envenoming and deaths across countries, accounting for differences in surveillance, underreporting, socioeconomic conditions, and environmental factors. The analysis highlights major gaps in epidemiological data and provides updated country- and regional-level estimates to help guide prevention, antivenom access, surveillance, and healthcare resources.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.